Woodford favourite AstraZeneca raises dividend but profits fall

clock

AstraZeneca, a stalwart of many income portfolios including Neil Woodford's, has said it will raise its dividend by 10% despite sounding an earnings warning for 2012.

The pharmaceutical giant reported pre-tax profits fell in Q4 to $2.05bn compared with $2.28bn in 2010. It also announced it is cutting a further 7,300 jobs and expects earnings to fall this year as patents on key drugs expire and governments in Europe and the US hit prices. It said it would begin a $4.5bn share buy-back scheme as well as increase its dividend by 10%. The UK's second-largest drugs firm has long been a mainstay for equity income managers and is Woodford's second largest holding in his Invesco Perpetual Income fund at 8.23% of the portfolio (as at January 2012). Th...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment

Over a quarter of younger investors own crypto as overall optimism on the rise in July

Over a quarter of younger investors own crypto as overall optimism on the rise in July

Optimism up from May figures

Sorin Dojan
clock 23 July 2025 • 2 min read
Partner Podcast: What clients really want from their managers

Partner Podcast: What clients really want from their managers

Listen to the latest postcast with Honor Solomon, CEO for EMEA and Head of EMEA Retail Sales, at AllianceBernstein

Honor Solomon, CEO for EMEA and Head of EMEA Retail Sales, at AllianceBernstein
clock 22 July 2025 • 1 min read
Dimensional's Kaitlin Hendrix: Counting the cost of index rebalancing

Dimensional's Kaitlin Hendrix: Counting the cost of index rebalancing

Reconstitutions can hurt returns

Kaitlin Hendrix
clock 18 July 2025 • 4 min read
Trustpilot